Validity and Test-Retest Reliability of Reactive Neurocognitive Upper Extremity Tests in Archers

NCT ID: NCT07103824

Last Updated: 2025-08-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-07

Study Completion Date

2025-05-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In archery, the evaluation of reaction time and neurocognitive functions plays a critical role in the management of upper extremity (UE) injuries and return-to-play (RTP) processes. Reaction time reflects an athlete's ability to respond quickly and effectively to visual stimuli, which is particularly crucial in precision-based sports like archery that require high levels of coordination and attention.

With advancements in technology, LED-based systems such as BlazePod™, Catchpad, and ReactionX are increasingly being used in clinical and sports settings to assess cognitive performance and motor responses simultaneously. These tools offer dynamic and motivating methods for evaluating neurocognitive functions. However, before such devices can be reliably used in clinical or research environments, their validity and test-retest reliability must be systematically examined.

The aim of this study is to evaluate the test-retest reliability and validity of Reactive Neurocognitive Upper Extremity Tests-specifically the Reactive Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST) and the Reactive 90/90 Wall Throws Test-using the Catchpad system in archers. Based on methodological standards for reliability studies, a minimum of 18 participants will be included. Each participant will attend three test sessions over three weeks: Catchpad in weeks one and three, and BlazePod™ in week two. To ensure blinding, different researchers will conduct the assessments, record the data, and perform the statistical analyses.

Findings from this study are expected to provide scientific evidence supporting the use of Catchpad technology in neurocognitive and reaction time assessments, contributing to more objective decision-making during RTP and potentially reducing the risk of reinjury.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Athlete Assessment Archery Neurocognitive Functional Performance Tests

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Upper Extremity Neurocognitive Tests

Group Type EXPERIMENTAL

Upper Extremity Neurocognitive Tests

Intervention Type OTHER

The validity and test-retest reliability of the Reactive Neurocognitive Upper Extremity Tests (Reactive CKCUEST and Reactive 90/90 Wall Throws Test) will be analyzed through this protocol. Participants will undergo three assessment sessions spaced one week apart: measurements will be conducted using the Catchpad device during the first and third weeks, and the BlazePod™ device during the second week. To ensure blinding, the personnel responsible for conducting the assessments, recording the data, and performing the statistical analyses will be distinct individuals. Participants will be familiarized with the devices one week prior to testing, and a standardized 5-minute free walking warm-up will be administered at each session. All assessments will be performed under similar environmental conditions and at consistent times of day.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Upper Extremity Neurocognitive Tests

The validity and test-retest reliability of the Reactive Neurocognitive Upper Extremity Tests (Reactive CKCUEST and Reactive 90/90 Wall Throws Test) will be analyzed through this protocol. Participants will undergo three assessment sessions spaced one week apart: measurements will be conducted using the Catchpad device during the first and third weeks, and the BlazePod™ device during the second week. To ensure blinding, the personnel responsible for conducting the assessments, recording the data, and performing the statistical analyses will be distinct individuals. Participants will be familiarized with the devices one week prior to testing, and a standardized 5-minute free walking warm-up will be administered at each session. All assessments will be performed under similar environmental conditions and at consistent times of day.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants must agree to abstain from alcohol and caffeine throughout the study period.
* Participants must refrain from engaging in vigorous physical activity for at least 24 hours prior to each testing session.
* Participants must not consume any food within 3 hours before the measurement.

Exclusion Criteria

* History of a back, lower extremity, or upper extremity injury within the past six months.
* Any known medical condition or diagnosis that may interfere with testing, including but not limited to neurological disorders.
* Vestibular disorders, color blindness, or the use of medications that could affect balance or visual-motor reaction time.
Minimum Eligible Age

10 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Balikesir University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ebru Tekin

Pamukkale University

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Balikesir University

Balıkesir, Bigadiç, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024/14

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.